Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with companies executive. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.
Glaukos announced Feb. 25 that its epi-on corneal cross-linking therapy for the treatment of keratoconus met its primary endpoint in a pivotal Phase III trial, demonstrating a statistically signifi...
Oyster Point Pharma announced March 2 that the US FDA had accepted its new drug application (NDA) for OC-01 (varenicline) nasal spray for the treatment of signs and symptoms of dry eye disease. The...
Glaukos reported Feb. 25 that its net sales for full year 2020 totaled $225 million, a decrease of 5 percent from $237.0 million in 2019. Q4-2020 net sales were $73.2 million, an 11 percent increas...
Iridex and Topcon announced March 2 that the companies will collaborate worldwide on glaucoma and retinal disease treatments. Iridex will get in $19.5 million in cash from Topcon in the deal. Topco...
Eyenovia, of New York, announced March 2 that the US FDA had accepted the company’s new drug application (NDA) for MydCombi, a fixed combination mydriatic (pupil dilation) agent. MydCombi (phenylep...
A group of top US scientists studying drug waste in single-dose vials has recommended eliminating the 6 percent add-on payment made to physicians for Medicare Part B drugs and instead reimbursing p...
Longtime ophthalmic innovator George Marcellino, PhD, died unexpectedly Feb. 10, 2021, Iridex reported on its website. Dr. Marcellino had been serving as Iridex’ vice president of clinical affairs ...
The University of Pittsburgh Medical Center (UPMC) announced Feb. 25 that a $20 million gift from the Henry L. Hillman Foundation will fund vision care research and development. The gift was made t...
The National Eye Institute and Association of Southeast Asian Nations Ophthalmology Society, along with experts from several renowned institutions, will hold a free virtual symposium in mid-March t...
Simulation innovators Optimo Medical AG and Ansys announced Feb. 23 that they have collaborated on a next-generation version of Optimo’s Optimeyes patient-specific surgical planning software for fa...
Boston Scientific of Marlborough, Massachusetts, announced March 3 that it was acquiring theLumenis surgical business for urology and otolaryngology (ears, nose, and throat, or ENT) from Baring Pri...
DTx Pharma, of San Diego, California, announced March 1 that it had completed a $100 million Series B financing. Arthur T. Suckow, PhD, chief executive officer of DTx Pharma, said the money would a...
Oxular Limited announced March 1 that it had completed a $37 million financing led by European life sciences venture capital firm Forbion. The Oxford, England, company said the money would fund Pha...
SalioGen Therapeutics of Burlington, Massachusetts, announced March 1 that it had closed a $20 million Series A financing to support development of nonviral gene therapies. Proceeds will be used fo...
Market Scope is tracking the status of 2021 ophthalmic meetings as the world tries to recover from COVID-19. Here is the latest information: Organization Status Date Location More Information Glauc...
Allergan, an AbbVie company, announced Feb. 25 that it had submitted a new drug application (NDA) to the US FDA for AGN-190584 (pilocarpine 1.25%) ophthalmic solution for symptoms of presbyopia. Th...
AcuFocus announced Feb. 23 that it had submitted a premarket approval (PMA) application to the US FDA for its IC-8 small aperture IOL. The IC-8 is an aspheric monofocal lens that features an embedd...
Alcon reported Feb. 23 that full-year 2020 revenue totaled $6.8 billion, a decrease of 8 percent on a reported and constant currency basis, from $7.4 billion in 2019. The company said a substantial...
Ophthalmologist Hema Ramkumar, MD, won the 2021 Winning Pitch Challenge—Retina, a virtual competition held Feb. 6. Ramkumar, a surgeon at Retina Consultants of Orange County, is the founder of Ocul...
Swiss ophthalmic surgical instrument maker Oertli announced Feb. 17 that it had started construction on a new factory at its location in Berneck. The three-story production and logistics building w...
I-MED Pharma, of Montreal, Canada, announced Feb. 2 that Keir Surgical had taken ownership of its ophthalmic surgical portfolio. No financial details were given. I-MED said it would reinvest the pr...
Medicom Healthcare Limited, of the UK, announced Feb. 10 that it had acquired the product dossier of bimatoprost 0.3 mg/mL, 3ml, preservative-free eye drop solution from Spain’s Famar Health Care S...
Ocugen announced Feb. 23that the European Commission had granted orphan medicinal product designation for its OCU400 gene therapy candidate for retinitis pigmentosa (RP) and Leber congenital amauro...
Australian company PYC Therapeutics, in a press release Feb. 22, cited progress in its transition to a US-based clinical-stage company, highlighting three RNA therapeutics in preclinical developmen...
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.